MedTrace Logo

"Study of the Effects of Serum and Follicular Fluid Relaxin Levels on Ovarian Function in IVF Cycles"

NCT04458454 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 11

Last updated 2020-07-07

No results posted yet for this study

Summary

The study evaluated the effect of serum relaxin and follicular fluid levels on the number and quality of oocytes, fertilization, the number and quality of the embryos in IVF protocols.

Conditions

  • Infertility
  • Reproductive Techniques, Assisted
  • Oocyte Maturation

Interventions

DIAGNOSTIC_TEST

Relaxin ELISA Kit

Ovarian stimulation was carried out from day 3 of the menstrual cycle using a fixed protocol, with recombinant (Gonal-F, Pergoveris) or human menopausal gonadotropins (Meriofert), GnRH antagonist (ganirelix 0.25 mg). A recombinant human chorionic gonadotropin Ovitrel 250 μg or a GnRH agonist, Diferelin 0.2 mg, was used as an ovulation trigger.

Sponsors & Collaborators

  • D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology

    lead OTHER

Principal Investigators

  • Olesya N Bespalova, MD, DSci · D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology

Eligibility

Min Age
20 Years
Max Age
43 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-02
Primary Completion
2020-02-20
Completion
2020-02-20

Countries

  • Russia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04458454 on ClinicalTrials.gov